C

Chatham-Kent Clinical Trials Research Centre | Chatham, Canada

Research site

(Unclaimed)

Location

240 Grand Ave W Suite #214, Chatham, Ontario, Canada

Site insights

Top conditions

Top treatments

BI 409306

PF-05212377

Troriluzole

Methylphenidate Hydrochloride

SEP-363856

Troriluzule

Lisdexamfetamine Dimesylate

BI 425809

Donepezil

Vortioxetine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 12 total trials

Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder

The purpose of the study is to evaluate the long term safety and tolerability of troriluzole as adjunctive therapy in subjects with obsessive compuls...

Invitation-only

Obsessive Compulsive Disorder

Drug: Troriluzole (BHV-4157)

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms